The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Oral Psoralen and Ultraviolet-A Light (PUVA) Treatment of Psoriasis and Persistent Risk of Nonmelanoma Skin Cancer
Abstract
BACKGROUND/METHODS: The treatment of psoriasis with high-dose exposure to oral psoralen and ultraviolet-A light (i.e., PUVA) substantially increases the risk of cutaneous squamous cell cancer, but not of basal cell cancer, within a decade of beginning treatment. To assess the persistence of cancer risk among individuals treated with PUVA, including those who discontinued therapy long ago and those without substantial exposure to other carcinogens, we prospectively studied a cohort of 1380 patients with psoriasis who were first treated during the period from January 1, 1975, through October 1, 1976, and evaluated risk factors associated with the development of cutaneous squamous cell cancers and basal cell cancers after 1985. RESULTS: From 1975 through 1996, 237 patients developed 1422 cutaneous squamous cell cancers. From 1986 through 1996, 135 (12.5%) of 1081 patients without a prior squamous cell cancer developed 593 such tumors. From 1975 through 1997, 247 patients developed 1042 basal cell cancers; these patients included 151 individuals with a first basal cell cancer after 1985. Among those without a squamous cell or a basal cell cancer in the first decade of the prospective study, a strong dose-related increase in the risk of squamous cell cancer was observed in the subsequent decade (adjusted relative risk [> or =337 treatments versus <100 treatments] = 8.6; 95% confidence interval = 4.9-15.2). Risk of basal cell cancer was substantially increased only in those patients exposed to very high levels of PUVA (> or =337 treatments). CONCLUSIONS: High-dose exposure to PUVA is associated with a persistent, dose-related increase in the risk of squamous cell cancer, even among patients lacking substantial exposure to other carcinogens and among patients without substantial recent exposure to PUVA. Exposure to PUVA has far less effect on the risk of basal cell cancer. The use of PUVA for psoriasis should be weighed against the increased cancer risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Photochemotherapy of Psoriasis with Oral Methoxsalen and Longwave Ultraviolet Light
Parrish, J. A., Fitzpatrick, T. B., Tanenbaum, L., & Pathak, M. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197412052912301 · Cited by 1,376
Stern, R. S., Nichols, K. T., & Väkevä, L. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361501 · Cited by 656
Self-citationMarks, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90081-1 · Cited by 581
Stern, R. S., Thibodeau, L. A., Kleinerman, R. A., Parrish, J. A., Fitzpatrick, T. B., & 22 Participating Investigators (1979) · New England Journal of Medicine · doi:10.1056/nejm197904123001501 · Cited by 558
Self-citationGallagher, R. P. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.2.157 · Cited by 551
Cutaneous Squamous-Cell Carcinoma in Patients Treated with PUVA
Stern, R. S., Laird, N., Melski, J., Parrish, J. A., Fitzpatrick, T. B., & Bleich, H. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405033101805 · Cited by 452
Self-citationIncidence of non-melanocytic skin cancer treated in Australia
Giles, G. G., Marks, R., & Foley, P. (1988) · BMJ · doi:10.1136/bmj.296.6614.13 · Cited by 357
Stern, R. S., & Lange, R. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12464137 · Cited by 334
Self-citationThe carcinogenic risk of treatments for severe psoriasis
Dahl, M. V. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)90084-5 · Cited by 318
Gallagher, R. P. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.2.164 · Cited by 309
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Toxic effects of ultraviolet radiation on the skin
Matsumura, Y., & Ananthaswamy, H. N. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.08.019 · Cited by 1,270
Review: Ultraviolet radiation and skin cancer
Narayanan, D. L., Saladi, R. N., & Fox, J. L. (2010) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2010.04474.x · Cited by 1,184
Madan, V., Lear, J. T., & Szeimies, R.-M. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61196-x · Cited by 884
Burmester, G. R., Panaccione, R., Gordon, K. B., McIlraith, M. J., & Lacerda, A. P. M. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201244 · Cited by 591
Metadata
- Authors
- Stern, R. S., Liebman, E. J., & Väkevä, L.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-09-02
- Volume
- 90
- Issue
- 17
- Pages
- 1278-1284
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2052364506
- Cited by
- 270
- References
- 27
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral Psoralen and Ultraviolet-A Light (PUVA) Treatment of Psoriasis and Persistent Risk of Nonmelanoma Skin Cancer. https://app.cochat.ai/papers/10.1093/jnci/90.17.1278
- The paper
- Stern, R. S., Liebman, E. J., & Väkevä, L. (1998). Oral Psoralen and Ultraviolet-A Light (PUVA) Treatment of Psoriasis and Persistent Risk of Nonmelanoma Skin Cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/90.17.1278
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.